Go Pro

Cue Biopharma (CUE) Insider Trading & Ownership

Cue Biopharma logo
$28.04 +1.76 (+6.70%)
As of 12:50 PM Eastern

Cue Biopharma (NASDAQ:CUE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
14.56%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$2.04M
Get CUE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cue Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CUE Insider Buying and Selling by Quarter

Cue Biopharma Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/13/2026
Michael Vincent Meluzio
VP
Sell5,628$30.09$169,346.52  
8/13/2026
Shao-Lee Lin
CEO
Sell18,258$28.62$522,543.96  
8/13/2026
Sumita Ray
Insider
Sell8,829$30.09$265,664.61  
8/12/2026
Shao-Lee Lin
CEO
Sell40,000$27.10$1,084,000.00  
(Data available from 1/1/2013 forward)

CUE Insider Trading Activity - Frequently Asked Questions

The list of insiders at Cue Biopharma includes Anish Suri, Daniel R Passeri, Michael Vincent Meluzio, Shao-Lee Lin, and Sumita Ray. Learn more on insiders at CUE.

14.56% of Cue Biopharma stock is owned by insiders. Learn more on CUE's insider holdings.

The following insider purchased CUE shares in the last 24 months: Daniel R Passeri ($30,591.00).

Insiders have purchased a total of 33 CUE shares in the last 24 months for a total of $30,591.00 bought.

The following insiders have sold CUE shares in the last 24 months: Michael Vincent Meluzio ($169,346.52), Shao-Lee Lin ($1,606,543.96), and Sumita Ray ($265,664.61).

Insiders have sold a total of 72,715 Cue Biopharma shares in the last 24 months for a total of $2,041,555.09 sold.



This page (NASDAQ:CUE) was last updated on 8/20/2026 by MarketBeat.com Staff.
From Our Partners